Medical News

---

• Specific types of childhood adversity linked to psychosis risk
• Prolidase levels increased in bipolar disorder
• Hospital visits after endoscopy higher than expected
• Airlines fail to warn passengers of thrombosis risk
• Blocking neurotransmitter could boost post-stroke recovery
• Genome-wide SNP for prostate cancer mortality remains unidentified
• Daily brisk walking may reduce postmenopausal breast cancer risk
• Genome-wide SNP for prostate cancer mortality remains unidentified
• Lipid subfractions associated with incident CHD
• Ezetimibe/simvastatin combination therapy effective in older adults
• Paricalcitol lowers albuminuria in patients with diabetic nephropathy
• Anti-diabetes benefits from drinking coffee linked to SHBG levels
• Everolimus-eluting stents reduce post-PCI restenosis and revascularization risk
• Imposed dietary salt restrictions 20 times more effective than optional initiatives
• Daily brisk walking may reduce postmenopausal breast cancer risk
• Mixed QoL effects after non-hormonal prostate cancer treatment
• AIDS linked with reduced prostate cancer risk
• Primary and secondary bilateral breast cancers share common features
• Small prostate size could indicate more aggressive prostate cancer
• No protection against breast cancer from green tea
• Introduction of PSA screening has reduced metastasis risk
• Survival improved by RT in addition to ADT for high-risk prostate cancer
• HER-2 amplification level linked to trastuzumab response in breast cancer

Specific types of childhood adversity linked to psychosis risk Posted: 04 Nov 2010 05:00 PM PDT Results from a UK study suggest that only certain adverse childhood experiences are associated with an increased risk for psychotic disorders in later life.

Prolidase levels increased in bipolar disorder Posted: 04 Nov 2010 05:00 PM PDT Prolidase levels are higher in patients with bipolar disorder than in those without the condition, and could serve as a trait marker in bipolar disorder diagnosis, say Turkish researchers.

Hospital visits after endoscopy higher than expected Posted: 04 Nov 2010 05:00 PM PDT With the help of a new automated system, researchers have observed that the incidence of related hospital visits within 2 weeks of endoscopy is two-to-three-fold higher than expected from previous estimates.

Airlines fail to warn passengers of thrombosis risk Posted: 03 Nov 2010 05:00 PM PDT The majority of world airlines do not warn passengers of the risk for traveler's thrombosis, concludes a study published in the journal Phleblogy.

Blocking neurotransmitter could boost post-stroke recovery Posted: 03 Nov 2010 05:00 PM PDT Blocking the increased tonic inhibition that occurs post-stroke results in "early and robust" gains in motor recovery in mice, shows a study in Nature.

Genome-wide SNP for prostate cancer mortality remains unidentified Posted: 03 Nov 2010 05:00 PM PDT The results of a genome-wide association study cast doubt on the existence of a genome-wide single nucleotide polymorphism that indicates potentially fatal prostate cancer.

Daily brisk walking may reduce postmenopausal breast cancer risk Posted: 03 Nov 2010 05:00 PM PDT Moderate physical activity may reduce the risk for postmenopausal breast cancer, even among women who are inactive prior to menopause and subsequently increase their activity levels, US study findings indicate.

Genome-wide SNP for prostate cancer mortality remains unidentified Posted: 03 Nov 2010 05:00 PM PDT The results of a genome-wide association study cast doubt on the existence of a genome-wide single nucleotide polymorphism that indicates potentially fatal prostate cancer.

Lipid subfractions associated with incident CHD Posted: 03 Nov 2010 05:00 PM PDT Results from a US study show that lipid subfractions are important indicators of coronary heart disease risk.

Ezetimibe/simvastatin combination therapy effective in older adults Posted: 03 Nov 2010 05:00 PM PDT Combination therapy with ezetimibe and simvastatin may provide an effective lipid-lowering option for older adults at high- or moderately high risk for coronary heart disease, research shows.

Paricalcitol lowers albuminuria in patients with diabetic nephropathy Posted: 03 Nov 2010 05:00 PM PDT The addition of the selective vitamin D receptor activator paricalcitol to standard renin-angiotensin-aldosterone system inhibition reduces residual albuminuria in patients with diabetic nephropathy, report researchers from the VITAL study.

Anti-diabetes benefits from drinking coffee linked to SHBG levels Posted: 03 Nov 2010 05:00 PM PDT Increased levels of sex hormone-binding globulin may account for the inverse association between caffeinated-coffee consumption and risk for Type 2 diabetes in postmenopausal women, say investigators.

Everolimus-eluting stents reduce post-PCI restenosis and revascularization risk Posted: 03 Nov 2010 05:00 PM PDT Results from two studies suggest that percutaneous coronary intervention with an everolimus-eluting stent reduces restenosis in patients with calcified coronary lesions and cardiac events in patients with a jailed side branch.

Imposed dietary salt restrictions 20 times more effective than optional initiatives Posted: 03 Nov 2010 05:00 PM PDT Australian researchers suggest that compulsorily restricting the salt content of processed foods to "moderate" levels may reduce the disease burden linked to high salt consumption by 18% compared with voluntary salt reduction initiatives.

Daily brisk walking may reduce postmenopausal breast cancer risk Posted: 03 Nov 2010 05:00 PM PDT Moderate physical activity may reduce the risk for postmenopausal breast cancer, even among women who are inactive prior to menopause and subsequently increase their activity levels, US study findings indicate.

Mixed QoL effects after non-hormonal prostate cancer treatment Posted: 02 Nov 2010 05:00 PM PDT Sexual dysfunction and urinary problems are common after radical prostatectomy, external beam radiotherapy, and brachytherapy, say researchers who reviewed how non-hormonal prostate cancer treatments impact patient quality of life.

AIDS linked with reduced prostate cancer risk Posted: 02 Nov 2010 05:00 PM PDT US study findings show that men with AIDS have a reduced risk for prostate cancer compared with men in the general population, which the researchers suggest could be a result of reduced prostate-specific antigen screening among HIV-infected men.

Primary and secondary bilateral breast cancers share common features Posted: 02 Nov 2010 05:00 PM PDT US researchers have demonstrated that hormone receptor status, tumor grade, and histological type are strongly concordant between primary and secondary bilateral breast cancers.

Small prostate size could indicate more aggressive prostate cancer Posted: 01 Nov 2010 05:00 PM PDT Prostate cancer patients with small prostates have worse histopathological outcomes than their counterparts with large prostates, report US researchers who hope that a small prostate will act as a "red flag" for treatment with surgery rather than observation.

No protection against breast cancer from green tea Posted: 01 Nov 2010 05:00 PM PDT Consumption of green tea does not protect against breast cancer, regardless of the number of cups drunk and the type of tea consumed, concludes a large Japanese study.

Introduction of PSA screening has reduced metastasis risk Posted: 31 Oct 2010 05:00 PM PDT Men diagnosed with prostate cancer after 1993 – when routine prostate-specific antigen screening was introduced – are less likely to experience disease spread than men diagnosed before 1993, study findings show.

Survival improved by RT in addition to ADT for high-risk prostate cancer Posted: 31 Oct 2010 05:00 PM PDT A combination of androgen deprivation therapy plus radiotherapy should be the standard approach to treating high-risk prostate cancer, say researchers.

HER-2 amplification level linked to trastuzumab response in breast cancer Posted: 31 Oct 2010 05:00 PM PDT A high level of human epidermal growth factor receptor 2 gene amplification is associated with a greater likelihood of achieving pathologic complete response in non-metastatic breast cancer patients treated with trastuzumab-based neoadjuvant therapy, French researchers report.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610